glp 1 muscle wasting Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do Muscle Loss with GLP-1 Medications:

The GLP-1 Receptor Agonist market size is expected to reach $18.32 billion in 2030 at a CAGR of 5.4%, driven by rising prevalence of diabetes.

for example, weight loss associated with the use of GLP-1 RAs in people without cancer may be associated with the prevention of obesity-related cancers

Millions of people seeking weight loss now have access to GLP-1 medications through telehealth platforms

Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years

GLP-1 users who carry an active Ozempic, Wegovy, Mounjaro, or Zepbound pen alongside a backup or transition pen

Based on: Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, et al